Frequencies for first 10,000 rows of drug7cl1 variable in nhamcsopd2003 dataset : drug class #1 for medication #7 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, unspecified | 1 0.01 0.01 anesthetics, local (injectable) | 18 0.18 0.19 anesthetics, general | 11 0.11 0.30 adjuncts to anesthesia/analeptics | 2 0.02 0.32 anesthetics, topical | 2 0.02 0.34 anesthetics, rectal | 1 0.01 0.35 penicillins | 3 0.03 0.38 cephalosporins | 6 0.06 0.44 erythromycins/lincosamides/macrolides | 2 0.02 0.46 aminoglycosides | 1 0.01 0.47 sulfonamides and trimethoprim | 5 0.05 0.52 urinary tract antiseptics | 1 0.01 0.53 antimycobacterial/anti-leprosy agents | 2 0.02 0.55 quinolones/derivatives | 2 0.02 0.57 antifungals | 3 0.03 0.60 antiviral agents | 6 0.06 0.66 deficiency anemias | 5 0.05 0.71 anticoagulants/thrombolytics | 17 0.17 0.88 blood components/substitutes | 1 0.01 0.89 cardiac glycosides | 3 0.03 0.92 antiarrhythmic agents | 4 0.04 0.96 antianginal agents | 4 0.04 1.00 vascular disorders, cerebral/peripheral | 3 0.03 1.03 antihypertensive agents | 25 0.25 1.28 diuretics | 25 0.25 1.53 relaxants/stimulants, urinary tract | 3 0.03 1.56 calcium channel blockers | 19 0.19 1.75 beta blockers | 19 0.19 1.94 alpha agonist/alpha blockers | 7 0.07 2.01 ace inhibitors | 20 0.20 2.21 sedatives and hypnotics | 17 0.17 2.38 antianxiety agents | 13 0.13 2.51 antipsychotic/antimanics | 4 0.04 2.55 antidepressants | 33 0.33 2.88 anorexiants/cns stimulants | 1 0.01 2.89 cns, miscellaneous | 1 0.01 2.90 diagnostics, radiopaque & nonradioactiv | 1 0.01 2.91 disorders, acid/peptic | 38 0.38 3.29 antidiarrheals | 1 0.01 3.30 laxatives | 8 0.08 3.38 miscellaneous gastrointestinals | 1 0.01 3.39 antispasmodics/anticholinergics | 1 0.01 3.40 antacids | 3 0.03 3.43 hyperlipidemia | 36 0.36 3.79 vitamins/minerals | 33 0.33 4.12 nutrition, enteral/parenteral | 1 0.01 4.13 repl/regs of electrolytes/water balance | 16 0.16 4.29 calcium metabolism | 6 0.06 4.35 hematopoietic growth factor | 1 0.01 4.36 adrenal corticosteroids | 5 0.05 4.41 androgens/anabolic steroids | 1 0.01 4.42 estrogens/progestins | 3 0.03 4.45 blood glucose regulators | 38 0.38 4.83 thyroid/antithyroid | 8 0.08 4.91 contraceptives | 1 0.01 4.92 growth hormone secretion disorder | 1 0.01 4.93 vaccines/antisera | 4 0.04 4.97 immunomodulators | 2 0.02 4.99 dermatologics, misc. | 3 0.03 5.02 topical steroids | 6 0.06 5.08 topical anti-infectives | 3 0.03 5.11 topical analgesics | 3 0.03 5.14 extrapyramidal movement disorders | 1 0.01 5.15 skeletal muscle hyperactivity | 6 0.06 5.21 anticonvulsants | 15 0.15 5.36 antineoplastics, miscellaneous | 3 0.03 5.39 hormonal/biological response mod. | 2 0.02 5.41 antimetabolites | 1 0.01 5.42 antibiotics,alkaloids,enzymes | 1 0.01 5.43 dna damaging drugs | 1 0.01 5.44 glaucoma | 2 0.02 5.46 ocular anti-infective/anti-inflammatory | 3 0.03 5.49 decongestants/antiallergy agents | 1 0.01 5.50 vertigo/motion sickness/vomiting | 6 0.06 5.56 analgesics/general | 1 0.01 5.57 analgesics, narcotic | 37 0.37 5.94 analgesics, non-narcotic | 40 0.40 6.34 antimigraine/other headaches | 3 0.03 6.37 antiarthritics | 7 0.07 6.44 antigout | 2 0.02 6.46 nsaid | 11 0.11 6.57 antiprotozoals | 1 0.01 6.58 antiasthmatics/bronchodilators | 18 0.18 6.76 nasal decongestants | 3 0.03 6.79 antitussives/expectorants/mucolytics | 2 0.02 6.81 antihistamines | 8 0.08 6.89 cold remedies | 1 0.01 6.90 corticosteroid-inhalation/nasal | 13 0.13 7.03 unclassified | 17 0.17 7.20 homeopathic products | 2 0.02 7.22 . | 9,278 92.78 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016